<DOC>
	<DOCNO>NCT02985346</DOCNO>
	<brief_summary>Pulmonary hemosiderosis ( PH ) pulmonary hemosiderin deposition cause alveolar capillary hemorrhage . PH easy recurrent lead pulmonary fibrosis insufficiency disease poor control . Steroid common drug administer acute phase disease . However , consider side-effects , steroid suitable long-time maintenance . Therefore , necessary explore new therapy . Bone marrow mesenchymal stem cell ( BMSC ) kind adult stem cell high self-renewal multi-directional differentiation potential bone marrow . It become hot topic immunosuppressive tissue repair therapy recent year . To date , homing , colonization differentiation BMSCs lung observe animal model pulmonary hypertension , radiation pneumonitis pulmonary fibrosis . It report BMSC transplantation acute lung injury mouse , inflammation lung injury significantly improve . The aim study explore effect BMSC PH mechanism , explore new way promote repair IPH . It expect improve status IPH therapy child , especially improve prognosis refractory PH .</brief_summary>
	<brief_title>Efficacy Bone Marrow Mesenchymal Stem Cell Pulmonary Hemosiderosis</brief_title>
	<detailed_description />
	<mesh_term>Hemosiderosis</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>Patients diagnose Pulmonary hemosiderosis age le 18 year . Patients finish establish cause die cause .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Idiopathic pulmonary hemosiderosis</keyword>
	<keyword>Bone marrow mesenchymal stem cell</keyword>
</DOC>